Results 171 to 180 of about 35,110 (216)

Targeted delivery of FAK siRNA by engineered exosomes to reverse cetuximab resistance via activating paraptosis in colon cancer. [PDF]

Apoptosis
Geng Y, Xia W, Zheng X, Chen L, Zhou Y, Feng J, Yuan Y, Zhang M, Lu J, Wei S, Hu W.   +10 more
europepmc   +1 more source

Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. [PDF]

Br J Cancer
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A.   +16 more
europepmc   +1 more source

Correction to "Stress-Induced Rab11a-Exosomes Induce Amphiregulin-Mediated Cetuximab Resistance in Colorectal Cancer". [PDF]

J Extracell Vesicles
europepmc   +1 more source

Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. [PDF]

Br J Cancer
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A.   +16 more
europepmc   +1 more source

MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her-2/PI3K/AKT Signaling. [PDF]

Adv Sci (Weinh), 2020
Han Y, Peng Y, Fu Y, Cai C, Guo C, Liu S, Li Y, Chen Y, Shen E, Long K, Wang X, Yu J, Shen H, Zeng S.   +13 more
europepmc   +1 more source

miR-100 and miR-125b induce cetuximab resistance in CRC [PDF]

Nature Reviews Gastroenterology & Hepatology, 2017
openaire   +1 more source

Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer. [PDF]

PLoS One, 2020
Nair S, Trummell HQ, Rajbhandari R, Thudi NK, Nozell SE, Warram JM, Willey CD, Yang ES, Placzek WJ, Bonner JA, Bredel M.   +10 more
europepmc   +1 more source

Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report [PDF]

, 2019
Callebout, Eduard, Claes, Kathleen, De Man, Marc, Ferdinande, Liesbeth, Geboes, Karen, Laurent, Stéphanie, Moura Ribeiro, Suzane, Van der Meulen, Joni   +7 more
core   +2 more sources

Pathway-Specific Genome Editing of PI3K/mTOR Tumor Suppressor Genes Reveals that PTEN Loss Contributes to Cetuximab Resistance in Head and Neck Cancer. [PDF]

Mol Cancer Ther, 2020
Izumi H, Wang Z, Goto Y, Ando T, Wu X, Zhang X, Li H, Johnson DE, Grandis JR, Gutkind JS.   +9 more
europepmc   +1 more source

Exploration of proteins involved in acquisition of resistance to cetuximab

Exploration of proteins involved in acquisition of resistance to cetuximab
Thesis or Dissertation 学位記番号 ...
openaire